0001209191-23-046246.txt : 20230817 0001209191-23-046246.hdr.sgml : 20230817 20230817161202 ACCESSION NUMBER: 0001209191-23-046246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230815 FILED AS OF DATE: 20230817 DATE AS OF CHANGE: 20230817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brownie William CENTRAL INDEX KEY: 0001827381 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39616 FILM NUMBER: 231182000 MAIL ADDRESS: STREET 1: C/O EARGO, INC. STREET 2: 2665 NORTH FIRST STREET, SUITE 300 CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eargo, Inc. CENTRAL INDEX KEY: 0001719395 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 273879804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2665 NORTH FIRST STREET STREET 2: SUITE 300 CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 650-351-7700 MAIL ADDRESS: STREET 1: 2665 NORTH FIRST STREET STREET 2: SUITE 300 CITY: SAN JOSE STATE: CA ZIP: 95134 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-15 0 0001719395 Eargo, Inc. EAR 0001827381 Brownie William C/O EARGO, INC. 2665 NORTH FIRST STREET, SUITE 300 SAN JOSE CA 95134 0 1 0 0 Interim CEO & COO 0 Common Stock 2023-08-17 4 S 0 14 3.23 D 8279 D Common Stock 2023-08-17 4 S 0 1500 3.204 D 6779 D Stock Option (Right to Buy) 3.305 2023-08-15 4 A 0 112500 0.00 A 2033-08-14 Common Stock 112500 112500 D Stock Option (Right to Buy) 3.305 2023-08-15 4 A 0 93750 A 2033-01-31 Common Stock 93750 93750 D Stock Option (Right to Buy) 11.58 2023-08-15 4 D 0 93750 D 2033-01-31 Common Stock 93750 0 D Stock Option (Right to Buy) 3.305 2023-08-15 4 A 0 93750 A 2033-01-31 Common Stock 93750 93750 D Stock Option (Right to Buy) 11.58 2023-08-15 4 D 0 93750 D 2033-01-31 Common Stock 93750 0 D Stock Option (Right to Buy) 3.305 2023-08-15 4 A 0 825 A 2031-01-28 Common Stock 825 825 D Stock Option (Right to Buy) 1051.60 2023-08-15 4 D 0 825 D 2031-01-28 Common Stock 825 0 D Reflects the number of shares of Common Stock that were sold to satisfy tax withholding requirements on vesting of restricted stock units pursuant to the Issuer's automatic sell to cover program, and does not represent a discretionary sale by the Reporting Person. The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date. The Issuer cancelled the Stock Option in exchange for a new Stock Option having a lower exercise price. The Stock Option vests and becomes exercisable as to 20% of the shares subject to the stock option on February 15, 2024 (the "Vesting Start Date"), with the remainder vesting in 16 equal quarterly installments thereafter until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date. The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, provided, that, any unvested portion of the Stock Option shall vest and become exercisable upon attainment of a 360-day VWAP (volume-weighted average price) of $20.00 for the Issuer's Common Stock, in either case, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date. The Stock Option vests and becomes exercisable in full upon attainment of a 360-day VWAP (volume-weighted average price) of $20.00 for the Issuer's Common Stock on or prior to February 15, 2028, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through such date. The Stock Option shall vest and become exercisable with respect to 16 quarterly installments commencing on February 15, 2021, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date. On January 17, 2023, the Issuer effected a 1-for-20 reverse stock split of its Common Stock (the "Reverse Stock Split"). These securities reflect the Reverse Stock Split. /s/ Christy La Pierre, Attorney-in-Fact for William Brownie 2023-08-17